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ABSTRACT 
 
Synthesis the new compound N-(4-methoxybenzoyl)-N’phenylurea has been done. The Schotten Baumann 
method was used for the reaction between N’phenylurea and 4-methoxybenzoyl chloride. The CNS depressant 
activity test was done for the N-(4-methoxybenzoyl)-N'phenylurea compound by Barbituric Sleeping Time 
(BST) method and compared with bromisoval as the standard compound and also with the parent compound N-
benzoyl-N’phenylurea. The compound yield was 73,24% , had a white crystal and gave one spot in Thin Layer 
Chromatography with two different eluents. The compound melting point was different from the N’phenylurea 
and showed greater. The structure identification from the new compound was analysed by UV, IR, 
1-
HNMR and 
MS, the result showed that the new compound was N-(4-methoxybenzoyl)-N’phenylurea. The CNS depressant 
activity test from N-(4-methoxybenzoyl)-N’phenylurea had  a greater activity if compare with the standard 
compound bromisoval and also with the parent compound N-benzoyl-N’phenylurea. 
  
Keywords:  N-(4-methoxybenzoyl)-N’phenylurea; Synthesis; CNS depressant activity test 
 
 
INTRODUCTION 
 
The experiment to looking for the new compound 
which has the specific activity of pharmacological 
effect is a challenge in this period.  In the health 
sector the development in the availability of a new 
molecule of drug is needed with further research to 
develop the structure of existing drug molecules or 
searching and finding new drug molecule which 
could be the candidate compounds that have potent 
pharmacological activity [12]. The chemical 
synthesis is one of the process to obtain a new 
compound that has the potential pharmacological 
effect as a new drug molecul candidate, of course 
with the new expectation that the new molecul drug 
compound relatively pure and has  higher 
pharmacological activity than the parent compound 
[4,7]. All the world and in Indonesia exactly known 
about urea which is a chemical compound and  
produced by the chemical industry. The use of urea 
compound in the world and also in Indonesia was 
limited as the fertilizer of the plants, it turns out on 
further development of one of the urea derivative 
compound that have pharmacological activity as a 
central nervous system depressant drug, namely 
bromisoval. This compound is used as a depressant 
of the central nervous system when the barbiturate 
derivatives are no longer effective as a depressant 
of the central nervous system [5,6].  The ureide 
acyclic structure (OCNH2CONH2) is existence on 
bromisoval compound and also on the barbiturate 
compounds that show pharmacological activity as a 
depressant of the central nervous system. Some 
researchers have succeeded in making urea 
derivatives which have pharmacological activity as 
a depressant of the central nervous system. 
Reksohadiprojo, 1981, has succeeded in making 
urea derivative compound namely isovalerilurea 
which also has a group pharmacophore ureide 
acyclic structure that have pharmacological activity 
as a depressant of the central nervous system [10]. 
Other researchers, Tjiptasurasa, 1991, has managed 
to create another instance of the urea compound 
bromasilurea which also has activity as a 
depressant of the central nervous system because of 
the compound also have a group pharmacophore 
ureide acyclic structure [15]. Siswandono, 1999has 
managed to make the benzoilurea derivatives 
contained therein pharmacophore acyclic ureide 
structure also have pharmacological activity as a 
depressant of the central nervous system [13].  
Suzanna, in 2004, managed to make the new 
compound of urea derivative benzoiltiourea who 
also have pharmacological activity as central 
nervous system depressant compound, it is also 
because of the group pharmacophore ureide acyclic 
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structure.[14] Further development of the urea 
derivatives is to try to create a new instance of the 
compound N-(4-methoxybenzoyl)-N'phenylurea 
which also has pharmacophore ureide acyclic 
structure so that the compound is also expected to 
have pharmacological activity as a central nervous 
system depressant compound. The synthesis 
method used to make urea derivative compounds 
mentioned above are using the  Schotten Baumann 
method which is has reaction principle between the 
amine group with the carbonyl group to form a 
carbamide compound [8,17]. To test the depressant 
activity of the central nervous system implemented 
by the Barbituric Sleeping Time (BST) method 
which consists of two steps, first is the 
determination of the timing of the peak activity and 
second is the potentiation  test of the compound 
[1,16,18]. 
 
EXPERIMENTAL WORK 
 
Synthesis of the N-(4-methoxybenzoyl)-
N'phenylurea compound: To make a urea 
derivative compound become the carbamide 
compound a method such as the Schotten Baumann 
method is needed because the reaction of the 
synthesis of the carbamide compound formation in 
one stage proccess [8,16]. Bambang Tri Purwanto, 
1991, it has successfully created ampicillin 
derivative compounds namely p-
bromobenzoilampisilin using Schotten Baumann 
method, by reacting between ampicillin compound 
with p-bromobenzoylchloride compound [2]. 
Bambang Tri Purwanto, 2012, has successfully too 
on synthesized N-benzoyl-N’phenylurea  using 
Schotten Baumann method, by reacting between 
N’phenylurea with benzoyl chloride compound [3].  
Siswandono, 1999, has made a new compound 
namely N-benzoylurea, also using the Schotten 
Baumann method which was reacted the urea 
compound with  benzoyl chloride [13]. In the 
synthesis of the N-(4-methoxybenzoyl)-
N'phenylurea compound was made through the 
reaction between  4-methoxy-benzoyl chloride 
compound (0.150 mol)  and N’phenylurea 
compound (0.125 mol) stirred and slowly mixed at 
a temperature of 0 - 5
o 
C. Then done stirring for 60 
minutes at room temperature. The next step is 
heating the mixture (refluxed) at a temperature of 
70
o
 C for 8 hours. Then added to a solution of 
saturated sodium bicarbonate, washed with water 
and then do recrystalization with hot methanol 
[8,18]. 
             
Structural characterization of the compound was 
carried out on the next stage with a variety of 
instruments, which can be proved that the 
compound which was synthesized has been 
successfully created [9,11]. 
The depressant activity test of the central 
nervous system: The method of the depressant 
activity test on the central nervous system is 
Barbituric Sleeping Time (BST), because this 
method is a standard method in the test of the 
depressant activity of the central nervous system. 
BST method consists of two stages, first the 
determination of the timing of the peak activity of 
the compound, which is to looked for the longest 
sleep time of the experimental animals, the second 
was the potentiating of the compound at the time of 
peak activity by giving compound thiopental 
induction [1,16,18]. The experimental animals 
which used were white mice (Mus musculus) aged 
2-3 months, had weigh between 20-30 g, BLAB C 
strain, without physical disabilities, and acquired 
from the  animals laboratory Airlangga University.  
 
In the depressant activity test of the central nervous 
system the compound N-(4-methoxybenzoyl)-
N'phenylurea on  the first stage is the determination 
of the peak activity time starts from minutes to 15, 
30, 45, 60, 75, 90 and 120 by using a single dose. 
The next stage is the determination of the 
potentiation test using 5 different doses (10, 25, 50, 
100 and 200 mg / kg BW) were administered by 
intraperitoneal routes. Bromisoval used as a 
standard compound  with the same dose, whereas 
the inducer compound is used thiopental sodium 
injection. The N-benzoyl-N’phenylurea was used as 
the parent compound. 
 
RESULT AND DISCUSSION 
 
The compound had been synthesized was white 
needle-shaped crystals with a yield gain of 73.24 
%, and it indicates that the method of Schotten 
Baumann was an elected method of the synthesis.  
In the first step  to prove that the compound had 
been synthesized, a  thin-layer chromatography test 
by using 2 different solvents (hexane: acetone = 4: 
2 and hexane: ethyl acetate = 4: 2) gave a single 
spot with different Rf and it showed a different Rf 
from N’phenylurea. The above showed that the 
target compound which was synthesized have been 
formed and relatively pure. In the next step, the 
melting point analysis test from the compound 
which was synthesized has a melting point 195
o
C 
and it was different from the N’phenylurea 
compound which have melting point 145
o
C. In this 
test has been proven that the compound synthesized 
have been formed and has a relatively of purity 
because there were no other impurities in it. The 
structure identification of the compound was 
synthesized performed by ultraviolet 
spectrophotometer, Infrared, 
1-
HNMR and mass 
spectrometer. The compound synthesized, UV 
(methanol solvent): λmaks (nm) = 252; IR (pellet 
KBr): 3446 cm
-1
 (NH secondary), 1685 cm
-1
; 1603 
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cm
-1
 (-CO), 1538;1515 cm
-1
 (C = C arom); 
1-
H-
NMR (DMSO-d6 solvent): 6.90 to 8.10, m, (C6H5), 
12.00 to 13.00,d,(NH), 3.70-4.10,s,(OCH3); MS 
(EI): 270 (M)
+
, 151 (C6H5NH)
+
.  The compound 
from N’phenylurea, UV (methanol solvent): λmaks 
(nm) = 204, 238; IR (pellet KBr): 3428 cm
-1
 (NH 
primary), 1655 cm
-1
 (CO), 1553 cm
-1
 (C = C 
aromatic); 
1-
H-NMR (DMSO-d6 solvent): 6.80 to 
8.00, m, (C6H5), 5.60, s, (NH), 6.20, s, (NH), 8.60, 
s, (NH2 ).  
 
In the structure identification with a variety of 
instruments the structure from the compound which 
was synthesized have different with the 
N’phenylurea compound, especially on the number 
of hydrogen atoms contained in the N’phenylurea 
compound (
1-
HNMR) and presence of 2 peaks from 
the carbonyl group (IR). On the characterization of 
the structure of the mass spectrometer showed that 
the synthesized compound have a molecular weight 
of 240 intact and the structure identification 
showed that suitable with that was shown on the 
literature so it can be ascertained that  the 
compound had been synthesized have formed 
[9,11],. The structure from the compound have 
been synthesized can be seen on figure 1. 
 
 
 
                Figure 1 : The structure of the N-(4-methoxybenzoyl)-N’phenylurea 
The depressant activity test of the central nervous 
system on the early stage, the compound which was 
synthesized had a peak activity at 30 minutes to the 
longest time sleeping mice, while the peak activity 
time for bromisoval 60 minute sleep mice showed 
the longest time. To test the inducer compound 
potentiation with thiopental, which was by  routes 
with 5 different doses can be seen in Figure 2 
below.
 
 
 
 
 
 
 
 
                      Figure 2: The central nervous system depressant activity test of N-benzoyl-N’phenylurea; N-(4-
methoxybenzoyl)-N'phenylurea and bromisoval 
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Based on the figure 2 shows that the activity of the 
compound N-(4-methoxybenzoyl)-N'phenylurea 
has the depressant activity of the central nervous 
system higher than the standard compound 
bromisoval at the same dose, also higher than the 
parent compound N-benzoyl-N’phenylurea, it is 
due to the addition of benzoyl group with methoxy 
moiety led to compound becomes more non-polar 
nature so it is very easy in penetration into 
biological membranes. Beside that, the N-(4-
methoxybenzoyl)-N'phenylurea compound has the 
same pharmacophore acyclic ureide too, so it 
showed an activity of the central nervous system 
depressant also.   Based on these results 
demonstrate that the N-(4-methoxybenzoyl)-
N'phenylurea obtained can be developed into a new 
drug candidate compound which has the depressant 
activity to  the central nervous system 
 
 
CONCLUSION  
 
The N-(4-methoxybenzoyl)-N'phenylurea had been 
synthesized and  had the depressant activity of the 
central nervous system is higher than the standard 
compound bromisoval and the parent compound N-
benzoyl-N’phenylurea. 
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